Once upon a time, 2020 was supposed to be a year of promise. The George W. Bush administration in the early 2000s touted it as
In today’s uncertain business landscape, it can be challenging to boost sales, let alone engage customers. Now, more than ever, an effective go-to-market strategy (GTM)
Amid the unprecedented economic uncertainty created by the Covid-19 pandemic, one thing is becoming clear. To survive – and even thrive – in the post-Covid
Companies and brands use the latest digital marketing techniques to develop a competitive advantage and strengthen their core competencies. A comprehensive digital marketing strategy is
Every technology sales leader is accustomed to using an array of email marketing tools or
Recent reports and the ongoing Covid-19 pandemic is shifting priorities and focus areas for global businesses. For several Sales leaders, being empathetic during this unprecedented time is turning into a number 1 focus area, for businesses at large, there seems to now be a shift from focusing on just profits to being more sustainable.
In today’s competitive marketplace, companies and businesses need to constantly come up with different marketing
Business Intelligence is not just a buzzword that will come and fade in a few
Sales is critical to every organization and over the past decade, this area has witnessed
Some of the most common sales challenges are those that will find light among any
The global fashion brand deepens its use of EDITED’s Retail Intelligence Platform, leveraging advanced AI and connected data to unify design, planning, and marketing teams. EDITED™, the leading retail intelligence platform, announced an expanded partnership with Cider, the global social-first
Latest platform release harnesses autonomous, agentic AI to deliver demonstrable, quantifiable results, driving next-level insights and efficiency in sourcing and supplier management Coupa, the leading AI platform for Total Spend Management, announced a significant platform release powered by agentic AI.
Zymeworks Inc., a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics announced the appointment of Scott Platshon as Acting Chief Investment Officer. Mr. Platshon will report directly to Zymeworks’ Chair
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
